Tyson Foods, Inc. (TSN) Stock Price Today
Aura AI Summary
Key Stats
- $18.09BMarket Cap
- -Volume
- Consumer StaplesSector
- $68.7552W High
- $50.7252W Low
- -Typical Hold Time
- $25.36BEnterprise Value
- 3.97%Div Yield
- -Trading Activity
Track Tyson Foods, Inc. (TSN) stock price today on Pluang, updated in real time with live charts and market data. Over the past 52 weeks, Tyson Foods, Inc. has traded between a low of $50.72 and a high of $68.75, highlighting its annual price range. Buy and sell Tyson Foods, Inc. shares on Pluang with fractional shares and real-time market data — safe and OJK-regulated.
About Tyson Foods, Inc.
Tyson Foods is the largest U.S. producer of processed chicken and beef. It's also a large producer of processed pork and protein-based products under the brands Jimmy Dean, Hillshire Farm, Ball Park, Sara Lee, Aidells, State Fair, and Raised & Rooted, to name a few. Tyson sells 81% of its products through various U.S. channels, including retailers (47% in fiscal 2021), food service (32%), and other packaged food and industrial companies (10%). In addition, 11% of the company's revenue comes from exports to Canada, Mexico, Brazil, Europe, China, and Japan.
Most Recent News
Nvidia CEO declares AGI achieved, powered by 100,000+ Grace Blackwell GPUs in new AI model training.
Nvidia CEO Jensen Huang announced that artificial general intelligence (AGI) has arrived, citing OpenAI's GPT-6 Astra model trained on over 100,000 Nvidia Grace Blackwell GPUs. This milestone highlights Nvidia's critical role in powering advanced AI ...

OpenAI hires Jessica Schumer to lead government outreach amid rising AI regulation talks.
OpenAI has hired Jessica Schumer, daughter of Senate Minority Leader Chuck Schumer, to manage government relations and partnerships in Northeastern states. Jessica Schumer brings extensive experience from Amazon and the Obama administration, strength...

Biotech ETF IBB outperformed S&P 500 by 22 points in 3 months amid pharma patent cliff deals.
The iShares Biotechnology ETF (IBB) surged 26% over three months ending September 4, 2026, outperforming the S&P 500's 4% gain by 22 points. This rally is driven by big pharmaceutical companies acquiring mid- and small-cap biotech firms to offset rev...

People also bought
Frequently Asked Questions
All investments involve risks and the possibility of a loss in investment value. Past performance is not indicative of future results. Historical performance, expected returns, and probability projections are provided for informational and illustrative purposes only.